Skip to content

Pulmonary Embolism Prognosis Model

Observation Study of Clinical Manifestation and Outcome in Chinese Pulmonary Embolism

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04411888
Enrollment
1500
Registered
2020-06-02
Start date
2020-06-01
Completion date
2024-06-01
Last updated
2020-06-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulmonary Embolism

Keywords

Pulmonary Embolism

Brief summary

The purpose of this study is to analyze the clinical manifestations, imaging features, and prognosis-related factors of pulmonary embolism, and to explore the prognosis risk assessment model for Chinese patients

Detailed description

Patients with pulmonary embolism and aged 18 years or older were enrolled in this study.Patient demographic characteristics((age, sex, department, diagnosis, ), basic vital signs, symptoms at their admissions (hemoptysis, dyspnea, chest pain, syncope), laboratory examinations (blood lab routines, blood gas, liver and kidney function, myocardial marker), and imaging examinations (vascular ultrasonography, computed tomographic angiography, echocardiography, chest CT, CTPA, pulmonary perfusion imaging, pulmonary angiography, PET/CT) were collected by reviewing the cases. The prognostic information was collected by telephone follow-up. The follow-up end point was June 2024.

Interventions

OTHERobservation

observation

Sponsors

Peking Union Medical College Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

Aged 18 years or older. Discharged with the diagnosis of PE from Peking Union Medical College Hospital.

Exclusion criteria

Diagnosed PE by other health care facility or transferred from other health care facility . Without important follow-up data.

Design outcomes

Primary

MeasureTime frameDescription
Patient survival timeThrough study completion, an average of 4 yearPatient survival time after diagnosed as pulmonary embolism

Countries

China

Contacts

Primary ContactJuhong Shi, M.D
shijh@pumch.cn+8613701178492
Backup ContactMin Peng, M.D
pengmin@pumch.cn+8613581888792

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026